Gargoyle Investment Advisor’s Allergan plc AGN Stock Holding History

Gargoyle Investment Advisor’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,703	Closed	-$1.27M	–	119
2019 Q1	$1.27M	Sell	8,703 -200	-2%	-$29K	1.23%	33
2018 Q4	$1.19M	Buy	+8,903	New	+$1.46M	1.09%	35
2017 Q4	–	Sell	-4,079	Closed	-$836K	–	207
2017 Q3	$836K	Buy	4,079 +1,219	+43%	+$283K	0.31%	94
2017 Q2	$696K	Hold	2,860	–	–	0.28%	99
2017 Q1	$683K	Hold	2,860	–	–	0.26%	107
2016 Q4	$601K	Hold	2,860	–	–	0.23%	115
2016 Q3	$659K	Hold	2,860	–	–	0.25%	118
2016 Q2	$661K	Buy	2,860 +60	+2%	+$13.8K	0.25%	121
2016 Q1	$750K	Sell	2,800 -200	-7%	-$57.3K	0.25%	130
2015 Q4	$938K	Hold	3,000	–	–	0.38%	90
2015 Q3	$815K	Hold	3,000	–	–	0.33%	96
2015 Q2	$910K	Buy	+3,000	New	+$895K	0.35%	93
2015 Q1	–	Sell	-8,122	Closed	-$2.09M	–	177
2014 Q4	$2.09M	Buy	8,122 +4,672	+135%	+$1.17M	0.77%	62
2014 Q3	$832K	Hold	3,450	–	–	0.31%	83
2014 Q2	$770K	Buy	+3,450	New	+$714K	0.29%	83

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gargoyle Investment Advisor's AGN Position: Q2 2019 in Review

Gargoyle Investment Advisor sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 8,703 shares — an estimated $1.27M sold.

Gargoyle Investment Advisor first reported a position in AGN in Q2 2014 and held it in 15 quarters. The position peaked at $2.09M in Q4 2014. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Gargoyle Investment Advisor reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Gargoyle Investment Advisor sold 8,703 Allergan plc shares in Q2 2019, an estimated $1.27M.
Gargoyle Investment Advisor first reported a position in Allergan plc in Q2 2014 and held it in 15 quarters.
Gargoyle Investment Advisor's Allergan plc position peaked at $2.09M in Q4 2014.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Gargoyle Investment Advisor's 13F filing for Q2 2019, filed 13 Aug 2019.